SIRT1 Protein

SIRT1 (Sirtuin 1) Protein

Overview

SIRT1 (Sirtuin 1) is an NAD+-dependent class III histone deacetylase (HDAC) of approximately 81 kDa that functions as a master regulator of cellular stress responses, metabolism, aging, and longevity. As a highly conserved NAD+-dependent deacetylase, SIRT1 removes acetyl groups from lysine residues on histones and numerous non-histone proteins, thereby modulating gene expression, protein function, and cellular homeostasis. In the nervous system, SIRT1 plays critical roles in neuronal survival, synaptic plasticity, memory formation, and has emerged as a significant protective factor in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [Huntington's disease](/diseases/huntingtons), and other neurodegenerative disorders[@haigis2006][@kim2007].

SIRT1 belongs to the sirtuin family of proteins, which are evolutionarily conserved from yeast to humans and require NAD+ as an essential cofactor. This NAD+ dependence links SIRT1 activity directly to cellular energy status and metabolic state, making it a unique therapeutic target at the intersection of metabolism and neurodegeneration.

SIRT1 (Sirtuin 1) Protein

Overview

SIRT1 (Sirtuin 1) is an NAD+-dependent class III histone deacetylase (HDAC) of approximately 81 kDa that functions as a master regulator of cellular stress responses, metabolism, aging, and longevity. As a highly conserved NAD+-dependent deacetylase, SIRT1 removes acetyl groups from lysine residues on histones and numerous non-histone proteins, thereby modulating gene expression, protein function, and cellular homeostasis. In the nervous system, SIRT1 plays critical roles in neuronal survival, synaptic plasticity, memory formation, and has emerged as a significant protective factor in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [Huntington's disease](/diseases/huntingtons), and other neurodegenerative disorders[@haigis2006][@kim2007].

SIRT1 belongs to the sirtuin family of proteins, which are evolutionarily conserved from yeast to humans and require NAD+ as an essential cofactor. This NAD+ dependence links SIRT1 activity directly to cellular energy status and metabolic state, making it a unique therapeutic target at the intersection of metabolism and neurodegeneration.

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">SIRT1 (Sirtuin 1)</th></tr>
<tr><td><strong>Protein Name</strong></td><td>SIRT1 (NAD-dependent deacetylase Sirtuin-1)</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SIRT1</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q96EB6">Q96EB6</a></td></tr>
<tr><td><strong>PDB Structures</strong></td><td>4IG0, 1ZC4, 5B2R, 5Y3F</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>81 kDa</td></tr>
<tr><td><strong>Amino Acids</strong></td><td>747</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Nucleus, Cytoplasm (shuttles between compartments)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Sirtuin family (Class III HDACs)</td></tr>
<tr><td><strong>Brain Expression</strong></td><td>High in cortex, hippocampus, cerebellum, hypothalamus</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-4bb7fd8c" style="color:#ce93d8" title="Score: 0.62">Nutrient-Sensing Epigenetic Circuit Reac...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1862 edges</a></td>
</tr>
</table>
</div>

Structure and Biochemistry

Catalytic Domain Architecture

SIRT1 possesses a modular structure optimized for its NAD+-dependent deacetylase activity[@bonkowski2014]:

• N-terminal region: Contains a flexible regulatory domain with nuclear localization signals (NLS) and binding sites for various activators and inhibitors. This region also contains sites for post-translational modifications that regulate SIRT1 activity.
• Catalytic core: The conserved Rossmann fold (~275 amino acids) comprises the enzymatic center, containing the NAD+-binding pocket and the substrate-binding groove. The active site features a conserved catalytic triad (His-363, Asn-395, His-402 in human SIRT1) that facilitates the deacetylation reaction.
• C-terminal region: A regulatory element that auto-inhibits catalytic activity through intramolecular interactions. This region can be cleaved by caspases, generating a truncated active form.

NAD+ Dependency and Mechanistic Insights

The unique NAD+ requirement of SIRT1 distinguishes it from classical HDACs:

• NAD+ binding: SIRT1 binds NAD+ in a conserved pocket, with binding affinity modulated by cellular NAD+/NADH ratios
• Deacetylation reaction: The mechanism involves formation of a covalent intermediate with ADP-ribose, followed by deacetylation and release of O-acetyl-ADP-ribose
• Metabolic coupling: Because NAD+ levels decline with age and in neurodegenerative diseases, SIRT1 activity provides a direct link between cellular metabolic state and gene regulation

Post-Translational Regulation

SIRT1 activity is regulated by multiple post-translational mechanisms:

• Phosphorylation: Multiple kinases (CK2, DYRK1A) phosphorylate SIRT1, modulating its activity
• Sumoylation: Sumoylation can enhance SIRT1 stability and activity
• Methylation: SETD7 methylates SIRT1, promoting its nuclear export
• Proteolytic processing: Caspase cleavage generates a truncated active form

Normal Function in the Nervous System

Epigenetic Regulation

SIRT1 functions as a major epigenetic regulator in the brain[@albani2014]:

• Histone deacetylation: Deacetylates H3K9, H3K14, H4K16 at promoter regions, creating a compact chromatin state that represses transcription
• Chromatin remodeling: Recruits and interacts with other chromatin-modifying complexes (e.g., SUV39H1, HDAC1/2) to coordinate epigenetic changes
• Gene-specific targeting: Directed to specific gene promoters through interactions with transcription factors, enabling context-specific regulation

Metabolic Control

SIRT1 integrates metabolic signals to regulate cellular energy homeostasis[@houtkooper2012]:

• PGC-1α activation: Deacetylates and activates PGC-1α (PPARGC1A), the master regulator of mitochondrial biogenesis
• FOXO deacetylation: Deacetylates FOXO transcription factors, shifting their activity toward antioxidant gene expression
• AMPK activation: SIRT1 activation can lead to AMPK activation, creating a positive feedback loop for metabolic regulation

Stress Response

SIRT1 is a central mediator of cellular stress responses:

• DNA damage response: Deacetylates p53, modulating its activity in DNA damage responses
• Oxidative stress: Through FOXO activation, SIRT1 promotes expression of antioxidant genes (MnSOD, catalase)
• Endoplasmic reticulum stress: Modulates the unfolded protein response through deacetylation of XBP1

Inflammation

SIRT1 has potent anti-inflammatory effects[@donner2020]:

• NF-κB inhibition: Deacetylates the p65 subunit of NF-κB, reducing its transcriptional activity and pro-inflammatory gene expression
• Microglial modulation: In microglia, SIRT1 deacetylates NF-κB and promotes anti-inflammatory phenotypes
• Inflammasome regulation: Modulates NLRP3 inflammasome activity through deacetylation

Autophagy

SIRT1 promotes autophagy through deacetylation of autophagy-related proteins[@pezzulo2013]:

• ATG proteins: Deacetylates ATG5, ATG7, ATG8, promoting autophagosome formation
• TFEB activation: Promotes nuclear translocation of TFEB, the master regulator of lysosomal biogenesis
• Quality control: Enhances clearance of damaged proteins and organelles through autophagy

Synaptic Plasticity and Memory

SIRT1 is essential for cognitive function:

• Synaptic protein regulation: Deacetylates synaptic proteins involved in glutamate receptor trafficking and signaling
• LTP modulation: SIRT1 activity enhances long-term potentiation through mechanisms involving AMPA receptor trafficking
• Memory formation: SIRT1 knockout mice display deficits in memory consolidation and retrieval

Role in Alzheimer's Disease

Amyloid-Beta Metabolism

SIRT1 protects against amyloid-beta (Aβ) pathology through multiple mechanisms[@qin2006]:

• ADAM10 activation: SIRT1 deacetylates and activates ADAM10, the α-secretase that promotes non-amyloidogenic APP processing
• BACE1 inhibition: SIRT1 can reduce β-secretase (BACE1) expression through epigenetic mechanisms
• Aβ clearance: SIRT1-enhanced autophagy facilitates clearance of Aβ aggregates

Tau Pathology

SIRT1 directly modulates tau pathology[@min2010]:

• Tau deacetylation: SIRT1 deacetylates tau at multiple lysine residues, promoting its degradation
• Acetylation-tau relationship: Hyperacetylated tau is more prone to aggregation and less efficiently cleared
• GSK-3β modulation: SIRT1 can modulate the activity of GSK-3β, a major tau kinase

Neuroinflammation

SIRT1 counteracts neuroinflammation in AD[@agrawal2018]:

• NF-κB deacetylation: Reduces pro-inflammatory cytokine expression
• Microglial phenotype: Promotes anti-inflammatory (M2) microglial activation
• Inflammasome modulation: Inhibits NLRP3 inflammasome activation

Mitochondrial Function

SIRT1 supports mitochondrial health in AD[@jahr2018]:

• Biogenesis: Through PGC-1α activation, promotes mitochondrial biogenesis
• Dynamics: Modulates mitochondrial fission/fusion balance
• Quality control: Enhances mitophagy to remove damaged mitochondria

Role in Parkinson's Disease

Dopaminergic Neuron Protection

SIRT1 protects the vulnerable dopaminergic neurons that degenerate in PD:

• Mitochondrial biogenesis: PGC-1α activation promotes mitochondrial function in dopaminergic neurons
• α-Synuclein clearance: SIRT1-enhanced autophagy can reduce α-synuclein aggregation
• Anti-apoptotic effects: FOXO deacetylation promotes pro-survival gene expression

Oxidative Stress

SIRT1 mitigates oxidative stress, a major pathogenic factor in PD:

• Antioxidant genes: Activates MnSOD and catalase through FOXO deacetylation
• NAD+ metabolism: PD is associated with NAD+ depletion; SIRT1 activation can counteract this
• Mitochondrial ROS: Reduces mitochondrial ROS production through improved function

LRRK2 Connection

SIRT1 may interact with LRRK2 pathogenic mechanisms:

• LRRK2 expression: Some evidence suggests SIRT1 can modulate LRRK2 expression
• Autophagy enhancement: LRRK2 mutants impair autophagy; SIRT1 activation may compensate

Role in Huntington's Disease

SIRT1 dysfunction contributes to Huntington's disease pathogenesis:

• mHTT interference: Mutant huntingtin protein directly interacts with and inhibits SIRT1
• PGC-1α repression: mHTT represses PGC-1α; SIRT1 activation can restore its function
• Transcription dysregulation: SIRT1's epigenetic functions are impaired by mHTT
• Therapeutic potential: SIRT1 activators have shown promise in HD models

Therapeutic Targeting

SIRT1 is a major therapeutic target for neurodegenerative diseases[@baur2010][@howitz2003]:

SIRT1 Activators

| Agent | Mechanism | Clinical Status | Notes |
|-------|-----------|----------------|-------|
| Resveratrol | Direct SIRT1 activation | Phase II/III | Natural polyphenol, limited bioavailability |
| SRT1720 | Direct SIRT1 activation | Preclinical | 1000x more potent than resveratrol |
| SRT2104 | Direct SIRT1 activation | Phase I | Improved pharmacokinetic properties |
| SRT3025 | Direct SIRT1 activation | Preclinical | Brain-penetrant |
| STAC-3 | SIRT1 activation | Preclinical | Novel synthetic activator |

NAD+ Boosting Strategies

| Agent | Mechanism | Clinical Status | Notes |
|-------|-----------|----------------|-------|
| NMN (Nicotinamide mononucleotide) | NAD+ precursor | Phase I/II | Directly increases SIRT1 activity |
| NR (Nicotinamide riboside) | NAD+ precursor | Phase I/II | Excellent brain penetration |
| NAMPT activators | Boost NAD+ synthesis | Research | Enhance endogenous NAD+ production |

SIRT1 Inhibitors (Research Tools)

• EX-527: Selective SIRT1 inhibitor used to study SIRT1 biology
• sirtinol: Broad sirtuin inhibitor
• Cambinol: SIRT1/2 inhibitor

Research Models and Methods

SIRT1 research employs diverse experimental approaches:

• Cell culture: Primary neurons, astrocytes, microglia
• Animal models: SIRT1 knockout mice, transgenic AD/PD/HD models
• Human tissue: Postmortem brain samples, iPSC-derived neurons
• Chemical biology: SIRT1 activity assays, screening for activators/inhibitors

Pathway & Interaction Diagram

Interactive diagram showing SIRT1's key relationships in the SciDEX knowledge graph (15 connections shown).

See Also

• [SIRT2 Protein](/proteins/sirt2-protein) — Related sirtuin
• [SIRT3 Protein](/proteins/sirt3-protein) — Mitochondrial sirtuin
• [PGC-1α](/proteins/pgc-1alpha) — SIRT1 target
• [FOXO3](/proteins/foxo3-protein) — SIRT1 target
• [Alzheimer's Disease](/diseases/alzheimers-disease) — Primary disease context
• [Parkinson's Disease](/diseases/parkinsons-disease) — Primary disease context
• [Huntington's Disease](/diseases/huntingtons) — Related disease

External Links

• [UniProt: SIRT1 (Q96EB6)](https://www.uniprot.org/uniprot/Q96EB6)
• [PDB: SIRT1 Structures](https://www.rcsb.org/search?searchType=advanced&proteinName=SIRT1)
• [GeneCards: SIRT1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SIRT1)
• [PubMed Search: SIRT1 Neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=sirt1+neurodegeneration)

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Nutrient-Sensing Epigenetic Circuit Reactivation](/hypothesis/h-4bb7fd8c) — <span style="color:#81c784;font-weight:600">0.62</span> · Target: SIRT1